Mark E. Cooper
- Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes 180
- Dialysis and Renal Disease Management 33
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research 134
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management 108
- Hormonal Regulation and Hypertension 47
- Cardiology and Cardiovascular Medicine top 0.05%
- Blood Pressure and Hypertension Studies 80
- Renin-Angiotensin System Studies 65
- Physiology top 0.2%
-
- Pancreatic function and diabetes 36
- Co-authors
- Josephine M. ForbesMerlin C. ThomasKarin Jandeleit‐DahmDick de ZeeuwGiuseppe RemuzziShahnaz ShahinfarBarry M. BrennerWilliam F. Keane
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark E. Cooper
501 papers receiving 47.5k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Nephrology 13.2k
- Clinical Biochemistry 8.5k
- Endocrinology, Diabetes and Metabolism 17.9k
- Cardiology and Cardiovascular Medicine 12.7k
- Physiology 5.4k
Countries citing papers authored by Mark E. Cooper
This map shows the geographic impact of Mark E. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Cooper more than expected).
Fields of papers citing papers by Mark E. Cooper
This network shows the impact of papers produced by Mark E. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Cooper. The network helps show where Mark E. Cooper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 16 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 77 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 42 | |
| 13 | 2020 | 29 | |
| 14 | 2019 | 112 | |
| 15 | 2018 | 37 | |
| 16 | 2017 | 121 | |
| 17 | 2013 | 5 | |
| 18 | 2010 | 188 | |
| 19 | 2005 | 6 | |
| 20 | 2004 | 260 |
About Mark E. Cooper
Mark E. Cooper is a scholar working on Nephrology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 514 papers that have together received 48.8k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (180 papers), Advanced Glycation End Products research (134 papers), Diabetes Treatment and Management (108 papers), Blood Pressure and Hypertension Studies (80 papers), Renin-Angiotensin System Studies (65 papers), Hormonal Regulation and Hypertension (47 papers), Pancreatic function and diabetes (36 papers) and Dialysis and Renal Disease Management (33 papers). The work is most often cited by research in Nephrology (13.2k citations), Clinical Biochemistry (8.5k citations) and Endocrinology, Diabetes and Metabolism (17.9k citations). Mark E. Cooper has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Josephine M. Forbes, Merlin C. Thomas, Karin Jandeleit‐Dahm, Dick de Zeeuw, Giuseppe Remuzzi, Shahnaz Shahinfar, Barry M. Brenner, William F. Keane, Hans‐Henrik Parving and William E. Mitch. Their work appears in journals such as Kidney International, Diabetes, Diabetologia, Journal of the American Society of Nephrology and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.